Sander Lefere

Long COVID: major findings, mechanisms and recommendations

The Interplay Between Tissue Niche and Macrophage Cellular Metabolism in Obesity

Chronic inflammation in the etiology of disease across the life span

Macrophages in immunoregulation and therapeutics

Inflammaging: a new immune–metabolic viewpoint for age-related diseases

Developmental control of macrophage function

Interaction between microbiota and immunity in health and disease

Epigenetic Regulation of Kupffer Cell Function in Health and Disease

Non-alcoholic fatty liver disease

The Pathobiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Case for Neuroglial Failure

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

Macrophages as regulators of tumour immunity and immunotherapy

Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?

Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis

PPAR control of metabolism and cardiovascular functions

Inflammation, metaflammation and immunometabolic disorders

Inflammation in obesity, diabetes, and related disorders

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review

Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease

The neurogliovascular unit in hepatic encephalopathy

Non-alcoholic steatohepatitis induces transient changes within the liver macrophage pool

Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages☆

Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease

Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism